Cite
APA Citation
Dignass, A., Danese, S., Matsuoka, K., Ferrante, M., Long, M., Redondo, I., Gibble, T. H., Moses, R., Li, X., Morris, N., Milch, C., Abreu, M., & Jones, J. (n.d.). a185 SUSTAINED SYMPTOM CONTROL WITH MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS IN THE LUCENT-2 MAINTENANCE TRIAL. Journal of the Canadian Association of Gastroenterology, 6, 29–31. http://access.bl.uk/ark:/81055/vdc_100179861500.0x000003